Is SCGVX or JNJ a better dividend investment in 2026?

SCGVX currently yields 56.51% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SCGVX offers higher current income.

What is the dividend yield difference between SCGVX and JNJ?

SCGVX has a forward dividend yield of 56.51% ($10.30/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 53.15 percentage points.

Home › Compare › SCGVX vs JNJ

SCGVX vs JNJ: Dividend Comparison 2026

SCGVX yields 56.51% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCGVX wins by $528.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCGVX

● Live price

56.51%

Share price

$18.22

Annual div

$10.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$548.3K

Annual income

$122,352.66

Full SCGVX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SCGVX vs JNJ

📍 SCGVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCGVX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCGVX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCGVX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCGVX

Annual income on $10K today (after 15% tax)

$4,803.43/yr

After 10yr DRIP, annual income (after tax)

$103,999.76/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SCGVX beats the other by $103,296.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCGVX + JNJ for your $10,000?

SCGVX: 50%JNJ: 50%

100% JNJ50/50100% SCGVX

Portfolio after 10yr

$284.1K

Annual income

$61,590.22/yr

Blended yield

21.68%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCGVX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCGVX buys

JNJ buys

No recent congressional trades found for SCGVX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCGVXJNJ

Forward yield	56.51% ✓	3.36%
Annual dividend / share	$10.30 ✓	$4.96
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$548.3K ✓	$20.0K
Annual income after 10y	$122,352.66 ✓	$827.78
Total dividends collected	$449.3K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SCGVX vs JNJ ($10,000, DRIP)

Year	SCGVX Portfolio	SCGVX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$16,351	$5,651.10	$10,676	$355.77	+$5.7K → SCGVX
2	$26,131	$8,635.67	$11,407	$389.39	+$14.7K → SCGVX
3	$40,859	$12,898.14	$12,198	$426.53	+$28.7K → SCGVX
4	$62,567	$18,848.02	$13,056	$467.62	+$49.5K → SCGVX
5	$93,920	$26,973.77	$13,987	$513.12	+$79.9K → SCGVX
6	$138,337	$37,841.92	$14,998	$563.56	+$123.3K → SCGVX
7	$200,112	$52,091.54	$16,098	$619.52	+$184.0K → SCGVX
8	$284,543	$70,423.70	$17,295	$681.69	+$267.2K → SCGVX
9	$398,047	$93,585.98	$18,599	$750.82	+$379.4K → SCGVX
10	$548,263	$122,352.66	$20,022	$827.78	+$528.2K → SCGVX

SCGVX vs JNJ: Complete Analysis 2026

SCGVX — Stock

The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests primarily in equity securities of publicly-traded companies located anywhere in the world, including equity securities in developed and emerging markets. Under normal market conditions, the Advisor expects to invest in at least three countries, including the United States, and invest at least 40% of its net assets, plus the amount of any borrowings for investment purposes, in non-U.S. companies.

Full SCGVX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SCGVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCGVX vs SCHD SCGVX vs JEPI SCGVX vs O SCGVX vs KO SCGVX vs MAIN SCGVX vs ABBV SCGVX vs MRK SCGVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.